In this episode of The Aftershock Podcast, I’m joined by Professor Marco Herold, a globally recognised expert in cancer research and the current CEO of the Olivia Newton-John Cancer Research Institute.
With a background in molecular biology and a passion for translating discoveries from bench to bedside, Professor Herold is leading groundbreaking efforts in cancer therapeutics, immunology, and personalised medicine.
In this episode, we dive into his journey from academic researcher to institute leader, the future of precision oncology, and how ONJCRI is bridging the gap between research and real-world impact for patients.